Marius Belmondo Tincho

8PUBLICATIONS
34CO-AUTHORS
NanomedicineGene and molecular therapyNanotoxicology, health and safetyInnate immunityBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 09, 2022
Author Correction: T cell responses to SARS-CoV-2 spike cross-recognize Omicron.

Roanne Keeton, Marius B Tincho, Amkele Ngomti

|Feb 01, 2022
T cell responses to SARS-CoV-2 spike cross-recognize Omicron.

Roanne Keeton, Marius B Tincho, Amkele Ngomti

|Dec 21, 2021
Escape from recognition of SARS-CoV-2 variant spike epitopes but overall preservation of T cell immunity.

Catherine Riou, Roanne Keeton, Thandeka Moyo-Gwete

|Oct 08, 2020
Cytotoxicity Potential of Endophytic Fungi Extracts from Terminalia catappa against Human Cervical Cancer Cells.

Michèle Stella Majoumouo, Marius Belmondo Tincho, Rufin Marie Kouipou Toghueo

|Oct 02, 2020
Synthesis of Biogenic Gold Nanoparticles from Terminalia mantaly Extracts and the Evaluation of Their In Vitro Cytotoxic Effects in Cancer Cells.

Michele S Majoumouo, Jyoti R Sharma, Nicole R S Sibuyi

Pageof 2